Development of inverse circadian blood pressure pattern in transgenic hypertensive TGR(mREN2)27 rats.

TGR(mREN2)27 (TGR) rats are transgenic animals with an additional mouse renin gene, which leads to overactivity of the renin-angiotensin system. Adult TGR rats are characterized by fulminant hypertension, hypertensive end-organ damage, and an inverse circadian blood pressure pattern. To study the ontogenetic development of cardiovascular circadian rhythms, telemetric blood pressure transmitters were implanted in male Sprague-Dawley (SPRD, n = 5) and heterozygous, transgenic TGR rats before 5 weeks of age. The TGR received either drinking water or enalapril 10 mg/L in drinking water (n = 5 per group). Drug intake was measured throughout the study by computerized monitoring of drinking volume. Circadian patterns in blood pressure and heart rate were analyzed from 5 to 11 weeks of age. In the first week after transmitter implantation, blood pressure did not differ among SPRD, untreated, and enalapril-treated TGR rats. In parallel with the rise in blood pressure of untreated TGR rats, a continuous delay of the circadian acrophase (time of fitted blood pressure maximum) was observed, leading to a complete reversal of the rhythm in blood pressure at an age of 8 weeks. Enalapril reduced blood pressure at night, but was less effective during the day, presumably due to the drinking pattern of the animals, which ingested about 90% of their daily water intake during the nocturnal activity period. After discontinuation of treatment, blood pressure returned almost immediately to values found in untreated TGR rats. In conclusion, the inverse circadian blood pressure profile in TGR rats develops in parallel with the increase in blood pressure. Direct effects of the brain renin-angiotensin system may be involved in the disturbed circadian rhythmicity in TGR(mREN2)27 rats.

[1]  R. Buijs,et al.  Effects of SCN lesions on circadian blood pressure rhythm in normotensive and transgenic hypertensive rats. , 1998, Chronobiology international.

[2]  B. Lemmer,et al.  Analysis of telemetric time series data for periodic components using DQ-FIT. , 1997, Chronobiology international.

[3]  R. Moore Chemical Neuroanatomy of the Mammalian Circadian System , 1997 .

[4]  H. van Essen,et al.  Disproportional arterial hypertrophy in hypertensive mRen-2 transgenic rats. , 1996, Hypertension.

[5]  Witte,et al.  ABPM-FIT and CV-SORT: an easy-to-use software package for detailed analysis of data from ambulatory blood pressure monitoring. , 1996, Blood pressure monitoring.

[6]  J. Ménard,et al.  Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats. , 1995, American journal of hypertension.

[7]  B. Lemmer,et al.  Effects of the Angiotensin II Receptor Antagonist Losartan on 24‐Hour Blood Pressure Profiles of Primary and Secondary Hypertensive Rats , 1995, Journal of cardiovascular pharmacology.

[8]  B. Lemmer,et al.  Free-running rhythms in blood pressure and heart rate in normotensive and transgenic hypertensive rats , 1995 .

[9]  J. Omens,et al.  Myocardial remodeling in hypertensive Ren-2 transgenic rats. , 1995, Hypertension.

[10]  D. Ganten,et al.  Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats , 1994, Peptides.

[11]  D. Ganten,et al.  Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene. , 1994, The American journal of physiology.

[12]  D. Ganten,et al.  Renal function in hypertensive rats transgenic for mouse renin gene. , 1994, The American journal of physiology.

[13]  D. Ganten,et al.  Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. , 1994, The American journal of physiology.

[14]  E. Reimann,et al.  Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. , 1994, Hypertension.

[15]  M. Middeke,et al.  Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension , 1994, BMJ.

[16]  D. Ganten,et al.  Effects of Enalaprilat on Circadian Profiles in Blood Pressure and Heart Rate of Spontaneously and Transgenic Hypertensive Rats , 1994, Journal of cardiovascular pharmacology.

[17]  D. Ganten,et al.  Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR(mREN2)27. , 1993, The American journal of physiology.

[18]  A Mattes,et al.  Circadian blood pressure variation in transgenic hypertensive rats. , 1993, Hypertension.

[19]  J. Mullins,et al.  Studies on blood pressure regulation in hypertensive ren-2 transgenic rats. , 1992, Kidney international. Supplement.

[20]  P. Parfrey,et al.  Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. , 1992, Kidney international.

[21]  T. Yamada,et al.  Prolonged Inhibition of Local Angiotensin‐Converting Enzyme After Single or Repeated Treatment with Quinapril in Spontaneously Hypertensive Rats , 1992, Journal of cardiovascular pharmacology.

[22]  D. Ganten,et al.  Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model. , 1992, Kidney international.

[23]  D. Ganten,et al.  Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene , 1990, Nature.